MarketInOut Stock Screener Log In | Sign Up
 

DexCom Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 06/01/2026 16:00
DexCom Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization28,454 mln
Float384 mln
Earnings Date07/23/2026

EPS

2.33
Stretched

P / E

32.13
Overvalued

Piotroski F-Score

9 / 9
Exceptional

Beneish M-Score

-3.16
Reliable

1-Year Forecast

82.04
Modest upside

Relative Strength

92 / 100
Top performer

Business Description

Dexcom is a San Diego-based medical device company founded in 1999 that builds and sells glucose monitoring technology for people living with diabetes and related conditions. Its product lineup includes wearable sensors and companion apps that track blood sugar levels continuously, removing the need for traditional finger-prick testing. The company sells its devices through healthcare professionals such as doctors and diabetes educators, and its products are available both in the United States and in markets around the world.

Key Fundamentals

EPS2.33
P/E32.13
ROE35.06
RPS11.99
ROIC25.94
ROA13.46
Interest Cover61.88
EBITDA, mln1,479
EV / EBITDA18.03
EV / EBIT21.85
Revenue, mln4,818
EV / Revenue5.54

Financial Strength

Altman Z-Score6.81
Piotroski F-Score 9 / 9
Beneish M-Score-3.16
Price to Intrinsic Value2.84
Price to Lynch Fair Value1.27
Price to Graham Number3.75
1-Year Target Price82.04
Shiller PE Ratio89.92
Short Ratio3.16
Short % of Float5.24

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.84% 75 / 100   
1 Month 25.73% 91 / 100   
2 Months 2.2% 50 / 100   
6 Months 19.73% 79 / 100   
1 Year -11.77% 25 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us